Treatment of chronic discoid lupus erythematosus with topical tacrolimus [5]

Acta Dermato-Venereologica

Volumn 84, Issue 3, 2004, Pages 233-234

  De La Rosa Carrillo, Daniel ^a   Christensen, Ole B ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; FLUOROURACIL; FOLINIC ACID; HYDROXYCHLOROQUINE; IRINOTECAN; PREDNISONE; TACROLIMUS;

CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; COLON CANCER; CORTICOSTEROID THERAPY; DISCOID LUPUS ERYTHEMATOSUS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LETTER; MONOTHERAPY; PRIORITY JOURNAL; RASH; TREATMENT OUTCOME;

EID: 2442579287     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310007698     Document Type: Letter

References (11)

1. Callen JP. Management of skin disease in patients with lupus erythematosus. Best Practice Res Clin Rheumatol 2002; 16: 245-264.
2. Housman TS, Jorizzo JL, McCarty MA, Grummer SE, Fleischer AB, Sutej PG. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol 2003; 139: 50-54.
3. Walker SL, Kirby B, Chalmers RJ. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 2002; 147: 405-406.
4. Walker SL, Kirby B, Chalmers RJ. Use of 0.1% tacrolimus ointment in patients with various forms of lupus erythematosus. Eur J Dermatol 2002; 12: 387-388.
5. Kanekura T, Yoshii N, Terasaki K, Miyoshi H, Kanzaki T. Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. Br J Dermatol 2003; 148: 353-356.
6. Yoshimasu T, Ohtani T, Sakamoto T, Oshima A, Furukawa F. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 2002; 12: 50-52.
7. Furukawa F, Yoshimasu T, Ohtani T, Ikeda K, Nishide T, Uede K. Topical tacrolimus therapy for lesions of cutaneous lupus erythematosus: reply to the comments of Drs. Walker, Kirby and Chalmers. Eur J Dermatol 2002; 12: 389.
8. McElwee KJ, Rushton DH, Trachy R, Oliver RF. Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model. Br J Dermatol 1997; 137: 491-497.
9. Yamamoto S, Kato R. Hair growth-stimulating effects of cyclosporin A and FK506 potent immunosuppressants. J Dermatol Sci 1994; 7 Suppl: S47-S54.
10. De Tran QH, Guay E, Chartier S, Tousignant J. Tacrolimus in dermatology. J Cutan Med Surg 2001; 5: 329-335.
11. Rodriguez Rilo HL, Subbotin VM, Selby RR, Thomson AW. Rapid hair regrowth in refractory alopecia universalis associated with autoimmune disease following liver transplantation and tacrolimus (FK506) therapy. Transplantation 1995; 59: 1350-1353.